QUOTE AND NEWS
Benzinga  Jul 30  Comment 
US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: NVGN) today confirmed it is committed to progressing its ground-breaking technology platforms to Phase 1 clinical trials as soon as practicable and to ensure the Company...
The Australian  Jul 29  Comment 
Novogen acting CEO Iain Ross has sought to reassure shareholders as he announced an urgent company-wide review.
Benzinga  Jul 22  Comment 
The Board of Directors of Novogen Limited (NASDAQ: NVGN) wishes to advise that it has accepted the resignation of its Chief Executive Officer and Director, Dr Graham Kelly, effective today. Dr Kelly has decided to leave the Company to resume...
The Australian  Jul 21  Comment 
Shares in cancer drug research firm Novogen tumbled after the sudden resignation of chief executive Graham Kelly.
The Australian  Jul 14  Comment 
Novogen shares leapt by over 10pc on news one of its drugs may improve the effectiveness of chemotherapy in children.
Benzinga  Jul 1  Comment 
In a report published Wednesday, HC Wainwright analyst Swayampakula Ramakanth initiated coverage of Novogen Limited (ADR) (NASDAQ: NVGN) with a Buy rating and $8.50 price target. The company has three drug candidates that target an addressable...
Benzinga  Jun 24  Comment 
Novogen Limited (NASDAQ: NVGN), announced today that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals, the result of which it now has been fast-tracked by the Company to come into the...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki